NUFORMIX PLC
Pharmaceutical developer using cocrystal technology to repurpose drugs for fibrosis.
NFX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYW79Y38
- LEI:
- 2138003XG3H3I2J3BJ24
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, EC3V 0HR LONDON
- Website:
- https://www.nuformix.com/
Description
Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-18 08:00 |
NXP001 Update
|
English | 11.3 KB | ||
| 2023-08-24 14:22 |
Result of Annual General Meeting
|
English | 21.4 KB | ||
| 2023-07-31 15:00 |
Notice of AGM
|
English | 10.6 KB | ||
| 2023-07-26 15:55 |
Holding(s) in Company
|
English | 51.3 KB | ||
| 2023-06-02 08:00 |
Investor Online Q&A
|
English | 9.1 KB | ||
| 2023-05-25 08:00 |
Change of Auditor
|
English | 9.6 KB | ||
| 2023-05-22 08:00 |
Unaudited Interim Report
|
English | 190.2 KB | ||
| 2023-05-18 08:00 |
NXP002 Inflammation and Duration of Action Update
|
English | 18.1 KB | ||
| 2023-04-26 11:55 |
Holding(s) in Company
|
English | 51.2 KB | ||
| 2023-04-17 08:00 |
Subscription to raise £70,000 & issue of Warrants
|
English | 12.8 KB | ||
| 2023-03-27 08:00 |
NXP002 Update
|
English | 15.7 KB | ||
| 2023-03-13 08:00 |
Change of Accounting Reference Date
|
English | 9.9 KB | ||
| 2023-02-15 08:00 |
NXP002 Update
|
English | 11.9 KB | ||
| 2023-01-03 14:37 |
Holding(s) in Company
|
English | 51.2 KB | ||
| 2022-12-20 14:00 |
Nuformix hoping to 'initiate discussions with major pharma' in 2023
|
English | 3.6 KB |
Automate Your Workflow. Get a real-time feed of all NUFORMIX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NUFORMIX PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NUFORMIX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
